Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products

Sep 13, 2011, 04:00 ET from Reportlinker

NEW YORK, Sept. 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products

http://www.reportlinker.com/p0365346/Emerging-Cancer-Diagnostic-Tests-and-Companies-Developing-New-Technologies-and-Products.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.

Contains 260 pages and 30 tables

Table of Contents

Major Current And Emerging Cancer Diagnostic Tests

1. Introduction

2. Tumor Marker Classification

3. ACTH

4. Alpha-Fetoprotein (AFP)

5. Beta-2 Microglobulin

6. CA 15-3/27.29

7. CA 19-9

8. CA-125

9. Calcitonin

10. Carcinoembrionic Antigen (CEA)

11. Estrogen and Progesterone Receptors

12. Ferritin

13. Gastrin

14. Human Chorionic Gonadotropin (HCG)

15. Insulin

16. Lymphocytes CD4/CD8

17. NSE

18. Occult Blood

19. PAP Smear/HPV

20. Prostatic Acid Phosphatase (PAP)

21. Prostate-Specific Antigen (PSA)

22. Squamous Cell Carcinoma Antigen (SCC)

23. TdT

24. Thyroglobulin

25. Tissue Polypeptide Antigen (TPA)

26. Biochemical Tumor Markers

ADA

B-Protein

PNP

5'-Nucleotidase

27. Oncogenes

Abl/abl-bcr

AIB1

APC

BTA 26

BCL-2

BCR-ABL

B-raf

BRCA

CD44

CDK

C-abl

C-fos

C-myb

C-myc

CYCD1

CYP-17

DPC

E-myc

Erb-B

HER-2/neu

HPC1

HSTF

L-myc

MET

MSH

NEU

N-myc

N-telopeptide

PCA3

PIK3CA

PTI-1

P10

P40

P51

P53

Ras

Reg

RET

sFas

Sis

Src

28. Polypeptide Growth Factors

Basic Fibroblast Growth Factor

Beta-TGF

Cachectin (TNT)

Calmodulin

ECFR

Nerve Growth Factor (NGF)

Epidermal Growth Factor (EGF)

Ornithine Decarboxylase

Transferrin

Transforming Growth Factor-Alpha

29. Ectopic Hormones

30. Colony Stimulating Factors

31. Lymphokines

Alpha-Interferon

B Cell Growth Factors

B Cell Growth Factor (BCGF)

Gamma-Interferon

Interleukin-1 (IL-1)

Macrophage Activating Factor

32. Immunohistochemical Stains

33. Emerging Tumor Markers

N-Acetylglucosamine

Actin

Alpha-Actin

Angiogenin

Angiostatin

Antineuronal Antibodies

7B2

B72.3

B-Protein

Bax

BCD-F9

BLCA-4

Blood Group Antigens A,B,H

BTA

CA 50

CA 72-4/TAG-72

CA 195

CA-242

CA-549

Cadherin

CAM 26

CAR-3

CD105

Cathepsin-D

Chromogranin A and B

Cluster 1 Antigen

Cluster-5/5A Antigen

COX Antigen

CTA

CU18

Cyclin

DR-70

DU-PAN-2

Endometrial Bleeding Associated Factor

Endostatin

Epithelial Membrane Antigen

FDP

Feulgen Hydrolysis

Fibronectin

FSH

(1->3)-L-fucosyltransferase

Gastrin-Releasing Peptide (GRP)

GDCFP-15

Glucagon

Glycoamines

H23

HAAH

hk3

HPA

HSP27

Human Carcinoma Antigen

ICAM

Intermediate Filaments

Cytokeratins/CK18/Cyfra 21-1

Desmin

Gliofibrillary Acid Protein

Neurofilaments

Vimentin

KA 93

Kallikrein

Kinases

KP16D3

LAI

Leukocyte Common Antigen

Lewis Antigens

Lysophosphatidic Acid (LPA)

Ma 695/Ma 552

MABDF3

MAG

ME1

Minactivin

MN/CA9

MSA

Mucin Cancer Antigen (MCA)

Multiple Tumor Suppressor 1

Myosin

NEA-130

NMP22

Nucleolar

OA-519

Opiod Peptides

P-glycoprotein

Pancreatic Oncofetal Antigen (POA)

Parathyrcoid Hormone

Placental Lactogen

PR92

Proliferative Index, Ki-67

Px

RB Inactivation/Deletion

Ret

S-100 Protein

SCCL 175

Selectin

Serotonin

Sialic Acid

Sialyl SSEA-1/SLX

SN10

Somatostatin

TA-90

TABA

Tachykinin

TAG 12

TPS

Troponin

Tubulin

VCAM

VEGF

Villen

White Blood Cell Markers

To order this report:

In Vitro Diagnostic Industry: Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com